Literature DB >> 1033668

Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device.

H J Tatum, F H Schmidt, A K Jain.   

Abstract

The clinical outcome of 918 pregnancies in women who conceived while using one or another of four models of the Copper T intrauterine contraceptive device (IUD) is presented. Elective abortion was chosen by 58 per cent of the women. The clinical management and course of 275 women who elected to allow their unplanned pregnancy to continue are described. The Copper T was either expelled or extracted during the pregnancy in 118 of the women, while the IUD remained in situ for the duration of the pregnancy in the remaining 157 patients. The incidence of spontaneous abortion more than doubled when the IUD remained in utero. The chance of a live birth being premature was four times greater when the IUD remained in situ than when it was removed. There were 27 ectopic pregnancies in this entire series, giving an incidence of 3.4 per cent. In addition, the data suggest, but do not prove, that there is an increased risk of having an ectopic pregnancy if the woman has worn the Copper T for more than two years. A benign fibroma of the vocal cord was the only congenital anomaly detected. These observations suggest that the incidence of developmental defects is not adversely affected by the presence of intrauterine copper.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1033668     DOI: 10.1016/0002-9378(76)90675-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Pregnancy with an intrauterine device in situ and preterm delivery.

Authors:  W Chaim; M Mazor
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

Review 2.  Treatment of preterm labour. A review of the therapeutic options.

Authors:  S N Caritis
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

3.  Deaths associated with intrauterine contraceptive devices in the United Kingdom between 1973 and 1983.

Authors:  P A Smith; C J Ellis; R A Sparks; J Guillebaud
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

4.  The intrauterine contraceptive device.

Authors:  B N Barwin; S Tuttle; E E Jolly
Journal:  Can Med Assoc J       Date:  1978-01-07       Impact factor: 8.262

5.  The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.

Authors:  Percy Pacora; Roberto Romero; Offer Erez; Eli Maymon; Bogdan Panaitescu; Juan Pedro Kusanovic; Adi L Tarca; Chaur-Dong Hsu; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-27

Review 6.  The prevalence and clinical significance of intraamniotic infection with Candida species in women with preterm labor.

Authors:  W Chaim; M Mazor; A Wiznitzer
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

7.  Transabdominal collection of amniotic fluid "sludge" and identification of Candida albicans intra-amniotic infection.

Authors:  Juan P Kusanovic; Roberto Romero; Carolina Martinovic; Karla Silva; Offer Erez; Eli Maymon; Francisco Díaz; Fernando Ferrer; Rafael Valdés; Víctor Córdova; Paula Vargas; María Elena Nilo; Patricio Le Cerf
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-03

8.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

9.  The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD).

Authors:  Sun Kwon Kim; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Pooja Mittal; Tinnakorn Chaiworapongsa; Percy Pacora; Giovanna Oggé; Ricardo Gomez; Bo Hyun Yoon; Lami Yeo; Ronald F Lamont; Sonia S Hassan
Journal:  J Perinat Med       Date:  2010       Impact factor: 1.901

10.  Ectopic pregnancy: a case-control study of aetiological risk factors.

Authors:  L Tuomivaara; A Kauppila
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.